ArticleBlood neoplasia2026
CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas.
Sanaz Mehdi Gholy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it